Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase

Cell

Volumn 98, Issue 5, 1999, Pages 675-686

  Chen, Hongwu ^a   Lin, Richard J ^b,c   Xie, Wen ^b   Wilpitz, Damien ^b   Evans, Ronald M ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; HISTONE; HISTONE ACETYLTRANSFERASE;

ACETYLATION; ARTICLE; CHROMATIN; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0033520325     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80054-9     Document Type: Article

References (62)

1. Braunstein, M., Rose, A.B., Holmes, S.G., Allis, C.D., and Broach, J.R. (1993). Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7, 592-604.
2. Brown, A.M., Jeltsch, J.M., Roberts, M., and Chambon, P. (1984). Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sei. USA 81, 6344-6348.
3. Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
4. Brzozowski, A.M., Pike, A.C., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L, Greene, G.L., Gustafsson, J.A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758.
5. Cavailles, V., Augereau, P., Garcia, M., and Rochefort, H. (1988). Estrogens and growth factors induce the mRNA of the 52K-procathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 16, 1903-1919.
6. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima,T., Schulman, I.G., Juguilon, H., Montminy, M., and Evans, R.M. (1996). Role of CBP/P300 in nuclear receptor signaling. Nature 383, 99-103.
7. Chen, K.S., and DeLuca, H.F. (1995). Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 7263, 1-9.
8. Chen, H., Lin, R.J., Schiltz, R.L, Chakravarti, D., Nash, A., Nagy, L, Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP p300. Cell 90, 569-580.
9. Darimont, B.D., Wagner, R.L, Apriletti, J.W., Stallcup, M.R., Kushner, P.J., Baxter, J.D., Fletterick, R.J., and Yamamoto, K.R. (1998). Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356.
10. Drach, J., Zhao, S., Malavasi, F., and Meht a, K. (1993). Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem. Biophys. Res. Commun. 795, 545-550.
11. Dubik, D., and Shiu, R.P. (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263, 12705-12708.
12. Fondell, J.D., Ge, H., and Roeder, R.G. (1996). Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sei. USA 93, 8329-8333.
13. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
14. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
15. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sei. USA 93, 11540-11545.
16. He, T.-C., Zhou, S., Costa, L.T.D., Yu, J., Kinzler, K.W., and Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sei. USA 95, 2509-2514.
17. Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.
18. Hong, H., Darimont, B.D., Ma, H., Yang, L, Yamamoto, K.R., and Stallcup, M.R. (1999). An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors. J. Biol. Chem. 274, 3496-3502.
19. Hyder, S.M., Chiappetta, C., Murthy, L, and Stancel, G.M. (1997). Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICH 82,780. Cancer Res. 57, 2547-2549.
20. Imhof, A., Yang, X.J., Ogryzko, V.V., Nakatani, Y., Wolffe, A.P., and Ge, H. (1997). Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7, 689-692.
21. Ito, M., Yuan, C.X., Malik, S., Gu, W., Fondell, J.D., Yamamura, S., Fu, Z.Y., Zhang, X., Qin, J., and Roeder, R.G. (1999). Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell 3, 361-370.
22. Jiang, H., Lin, J., Su, Z.Z., Collait, F.R., Huberman, E., and Fisher, P.B. (1994). Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9, 3397-3406.
23. Kadonaga, J.T. (1998). Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92, 307-313.
24. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.C., Heyman, R.A., Rose, D.W., Glass, C.K., and Rosenfeld, M.G. (1996). ACBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
25. Kontani, K., Nishina, H., Ohoka, Y., Takahashi, K., and Katada, T. (1993). NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J. Biol. Chem. 268, 16895-16898.
26. Kraus, W.L, and Kadonaga, J.T. (1998). p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12, 331-342.
27. Kuo, M.H., Brownell, J.E., Sobel, R.E., Ranalli, T.A., Cook, R.G., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Transcriptionlinked acetylation by Gcn5p of histone H3 and H4 at specific lysines. Nature 383, 269-272.
28. Kuo, M.H., Zhou, J., Jambeck, P., Churchill, M.E., and Allis, C.D. (1998). Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. 12, 627-639.
29. Lanz, R.B., McKenna, N.J., Onate, S.A., Albrecht, U., Wong, J., Tsai, S.Y., Tsai, M-J., and O'Malley, B.W. (1999). Asteroid receptorcoactivator, SRA, functions as an RNAand is present in an SRC-1 complex. Cell 97, 17-27.
30. Lin, R.J., Nagy, L, Inoue, S., Shao, W., Miller, W.H., Jr., and Evans, R.M. (1998). Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 397, 811-814.
31. Liu, M., Lee, M.H., Cohen, M., Bommakanti, M., and Freedman, L.P. (1996). Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153.
32. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
33. Mclnerney, E.M., Rose, D.W., Flynn, S.E., Westin, S., Mullen, T.M., Krones, A., Inostroza, J., Torchia, J., Nolle, R.T., Assa-Munt, N., et al. (1998). Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12, 3357-3368.
34. Mizzen, C.A., Yang, X.J., Kokubo, T., Brownell, J.E., Bannister, A.J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S.L., Kouzarides, T., Nakatani, Y., and Allis, C.D. (1996). The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261-1270.
35. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., and Thanos, D. (1998). Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2, 457-467.
36. Nagy, L, Kao, H.Y., Chakravarti, D., Lin, R.J., Hassig, C.A., Ayer, D.E., Schreiber, S.L, and Evans, R.M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSinSA, and histone deacetylase. Cell 89, 373-380.
37. Nolle, R.T., Wisely, G.B., Westin, S., Cobb, J.E., Lambert, M.H., Kurokawa, R., Rosenfeld, M.G., Willson, T.M., Glass, C.K., and Milburn, M.V. (1998). Ligand binding and co-aclivalor assembly of I he peroxisome proliferafor-aclivaled receptor-gamma. Nature 395, 137-143.
38. Ogryzko, V.V., Schlitz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
39. Ogryzko, V.V., Kotani, T., Zhang, X., Schlitz, R.L., Howard, T., Yang, X.J., Howard, B.H., Qin, J., and Nakatani, Y. (1998). Histone-like TAFs within the PCAF histone acetylase complex. Cell 94, 35-44.
40. Orlando, V., Strutt, H., and Paro, R. (1997). Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11, 205-214.
41. Perlmann, T., and Evans, R.M. (1997). Nuclear receptors in Sicily: all in the famiglia. Cell 90, 391-397.
42. Pratt, M.A.C., Deonarine, D., Teixeira, C., Novosad, D., Tate, B.F., and Grippo, J.F. (1996). The AF-2 region of the retinoic acid receptor alpha mediates retinoic acid inhibition of estrogen receptorfunction in breast cancer cells. J. Biol. Chem. 277, 20346-20352.
43. Rachez, C., Suldan, Z., Ward, J., Chang, C.P., Burakov, D., Erdjument-Bromage, H., Tempst, P., and Freedman, L.P. (1998). A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12, 1787-1800.
44. Robertson, K.A., Emami, B., and Collins, S.u. (1992). Retinoic acidresistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80, 1885-1889.
45. Rundlett, S.E., Carmen, A.A., Suka, N., Turner, B.M., and Grunstein, M. (1998). Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3. Nature 392, 831-835.
46. Ryu, S., Zhou, S., Ladurner, A.G., and Tjian, R. (1999). The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397, 446-450.
47. Sasaki, K., Cripe, T.P., Koch, S.R., Andreone, T.L., Petersen, D.D., Beale, E.G., and Granner, D.K. (1984). Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J. Biol. Chem. 259, 15242-15251.
48. Schutz, R.L, Mizzen, C.A., Vassilev, A., Cook, R.G., Allis, C.D., and Nakatani, Y. (1999). Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274, 1189-1192.
49. Shiau, A.K., Barstad, D., Loria, P.M., Cheng. L, Kushner, P.J., Agard, D.A., and Greene, G.L. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937.
50. Spencer, T.E., Jenster, G., Burcin, M .M., Allis, C.D., Zhou, J., M izzen, C.A., McKenna, N.J., Onate, S.A.,Tsai, S.Y.,Tsai, M.J., and O'Malley, B.W. (1997). Steroid receptor coactivator-1 Isa histone acetyltransferase. Nature 389, 194-198.
51. Struhl, K. (1998). Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 72, 599-606.
52. Torchia, J., Rose, D.W., Inostroza, J., Kamel, Y., Westin, S., Glass, C.K., and Rosenfeld, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
53. Torchia, J., Glass, C., and Rosenfeld, M.G. (1998). Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10, 373-383.
54. Voegel, J.J., Heine, M.J., Tini, M., Vivat, V., Chambon, P., and Gronemeyer, H. (1998). The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17, 507-519.
55. Wade, P.A., and Woffle, A.P. (1997). Histone acetyltransferases in control. Curr. Biol. 7, R82-R84.
56. Wang, L, Liu, L., and Berger, S.L. (1998). Critical residues for histone acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo. Genes Dev. 12, 640-653.
57. Watanabe, T., Inoue, S., Hiroi, H., Orimo, A., Kawashima, H., and Muramatsu, M. (1998). Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18, 442-449.
58. Workman, J.L., and Kingston, R.E. (1998). Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67, 545-579.
59. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. (1996). A p300 CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
60. Yao, T.P., Ku, G., Zhou, N., Scully, R., and Livingston, D.M. (1996). The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sei. USA 93, 10626-10631.
61. Yuan, C.X., Ito, M., Fondell, J.D., Fu, Z.Y., and Roeder, R.G. (1998). The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sei. USA 95, 7939-7944.
62. Zou, A., Elgort, M.G., and Allegretto, E.A. (1997). Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J. Biol. Chem. 272, 19027-19034.